Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Isolation, structure determination and cytotoxic activity of AJI-9561

Feb. 8, 2001

Novel DNA crosslinker with potential in the treatment of cisplatin-resistant ovarian cancer

Feb. 8, 2001

Phase II study examines IMC-C225 in combination with other agents for NSCLC

Feb. 8, 2001

NewBiotics and Elan form joint venture to develop colon cancer therapy

Feb. 8, 2001

Japanese labs design new series of ribonucleotide reductase inhibitors

Feb. 7, 2001

YM BioSciences extends EGF cancer vaccine trial to include U.K. sites

Feb. 7, 2001

Results with INGN-201 indicate new strategy for cancer immunotherapy

Feb. 7, 2001

Promising preliminary clinical results reported for Cell Therapeutics' PG-TXL

Feb. 7, 2001

Phase III trials of Thymitaq to begin in Canada

Feb. 7, 2001

Phase I leukemia data on Troxatyl published

Feb. 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...